Key growth drivers in the CIDP therapeutics market include rising prevalence, government funding for rare diseases, and the introduction of advanced treatment protocols that focus on early and effective intervention. https://www.marketresearchfuture.com/reports/chronic-inflammatory-demyelinating-polyneuropathy-market-6947